These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30118965)

  • 1. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
    Ghantous Y; Bahouth Z; Abu El-Naaj I
    Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORAOV1 is amplified in oral squamous cell carcinoma.
    Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
    J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.
    Reis PP; Waldron L; Perez-Ordonez B; Pintilie M; Galloni NN; Xuan Y; Cervigne NK; Warner GC; Makitie AA; Simpson C; Goldstein D; Brown D; Gilbert R; Gullane P; Irish J; Jurisica I; Kamel-Reid S
    BMC Cancer; 2011 Oct; 11():437. PubMed ID: 21989116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
    Pérez-Sayáns M; Chamorro-Petronacci CM; Lorenzo-Pouso AI; Peñaranda JMS; López-López J; Blanco-Carrión A; García-García A
    Cancer Biomark; 2020; 27(1):95-103. PubMed ID: 31683463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR copy number alterations in primary tumors, metastatic lymph nodes, and recurrent and multiple primary tumors in oral cavity squamous cell carcinoma.
    Huang SF; Chien HT; Cheng SD; Chuang WY; Liao CT; Wang HM
    BMC Cancer; 2017 Aug; 17(1):592. PubMed ID: 28854970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2.
    Shaw RJ; Hobkirk AJ; Nikolaidis G; Woolgar JA; Triantafyllou A; Brown JS; Liloglou T; Risk JM
    Ann Surg Oncol; 2013 Aug; 20(8):2796-802. PubMed ID: 23111707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
    Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
    Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.
    Ganci F; Sacconi A; Manciocco V; Sperduti I; Battaglia P; Covello R; Muti P; Strano S; Spriano G; Fontemaggi G; Blandino G
    Head Neck; 2016 Apr; 38 Suppl 1():E189-97. PubMed ID: 25532855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
    Kamat MS; Puranik RS; Das Rai AB; Patil BR; Patil S
    Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
    Vincent-Chong VK; Salahshourifar I; Woo KM; Anwar A; Razali R; Gudimella R; Rahman ZA; Ismail SM; Kallarakkal TG; Ramanathan A; Wan Mustafa WM; Abraham MT; Tay KK; Zain RB
    PLoS One; 2017; 12(4):e0174865. PubMed ID: 28384287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of ZASC1 gene copy number in recurrent oral carcinoma.
    Chiang WF; Hung PS; Liu SY; Yuan TC; Chang KW; Chen YP; Liu YC; Lin SC
    Oral Dis; 2011 Jan; 17(1):53-9. PubMed ID: 20646234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome instability in tumor resection margins of primary OSCC is a predictor of local recurrence.
    Pierssens DDCG; Borgemeester MC; van der Heijden SJH; Peutz-Kootstra CJ; Ruland AM; Haesevoets AM; Kessler PAWH; Kremer B; Speel EM
    Oral Oncol; 2017 Mar; 66():14-21. PubMed ID: 28249643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic alterations in the tumour, tumour margins, and normal buccal mucosa of patients with oral cancer.
    Eljabo N; Nikolic N; Carkic J; Jelovac D; Lazarevic M; Tanic N; Milasin J
    Int J Oral Maxillofac Surg; 2018 Aug; 47(8):976-982. PubMed ID: 29449053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
    Wang X; Chen S; Chen X; Zhang C; Liang X
    J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
    Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
    Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Her-2 protein in histologically tumor-free margins of oral squamous cell carcinoma: An immunohistochemical study.
    Kamat M; Puranik RS; Rai BD; Patil BR; Varsha VK; Kamat S
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S417-S421. PubMed ID: 37148009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
    Mohanta S; Sekhar Khora S; Suresh A
    Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.